492 results on '"Kim, Se Ik"'
Search Results
152. Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma
153. NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
154. Computational modeling of malignant ascites reveals CCL5–SDC4 interaction in the immune microenvironment of ovarian cancer
155. Development of a deep learning-based auto-segmentation algorithm for peritoneal metastases using CT image analysis of ovarian cancer.
156. Additional file 2 of Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
157. Single-arm, phase II study of niraparib and bevacizumab maintenance in platinum-sensitive, recurrent ovarian cancer previously treated with a PARP-inhibitor: KGOG3056/NIRVANA-R
158. The real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: a multicenter study in South Korea
159. Post-LACC era: critical assessment not “all-or-none” is needed
160. Incorporation of protein biomarkers to the ProMisE molecular classifier for further prognostication in endometrial cancer
161. Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
162. Impact of hemodynamic instability during radical hysterectomy on survival outcome in early cervical cancer
163. Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
164. Effect of BRCA mutational status on survival outcomes after secondary cytoreduction in platinum-sensitive relapsed ovarian cancer
165. Clinical practice patterns in the management of cervical, ovarian, and endometrial cancers in Asia-Pacific: a survey of the KSGO, JSGO, GCGS, and ANZGOG
166. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy
167. Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline BRCA1/2 Mutation Carriers: A Retrospective Cohort Study
168. Sarcopenia: Clinical implications in ovarian cancer, diagnosis, etiology, and management
169. Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
170. Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy
171. Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer
172. Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
173. A Randomized Controlled Trial of Thermo-Sensitive Sol–Gel Anti-Adhesion Agent after Gynecologic Surgery
174. Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor
175. Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
176. Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
177. Risk of Female-Specific Cancers According to Obesity and Menopausal Status in 2·7 Million Korean Women: Similar Trends Between Korean and Western Women
178. Ensemble of deep learning models to predict platinum resistance in high grade serous ovarian cancer
179. Systematic investigation of hyperparameters on performance of deep neural networks: application to ovarian cancer phenotypes
180. Ensemble of deep learning models to predict platinum resistance in high grade serous ovarian cancer
181. Systematic investigation of hyperparameters on performance of deep neural networks: application to ovarian cancer phenotypes
182. Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
183. Clinical Desire for an Artificial Intelligence–Based Surgical Assistant System: Electronic Survey–Based Study (Preprint)
184. Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells
185. Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study
186. Inhibition of miR-214-3p Aids in Preventing Epithelial Ovarian Cancer Malignancy by Increasing the Expression of LHX6
187. Identification of hyperparameters with high effects on performance of deep neural networks: application to clinicopathological data of ovarian cancer
188. Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer
189. Effect of postoperative adjuvant treatment in the therapeutic management of stage I, morcellated uterine leiomyosarcoma: A Korean multicenter study.
190. Bevacizumab Efficacy and Recurrence Pattern of Persistent and Metastatic Cervical Cancer
191. Ovarian Cancer Prognostic Prediction Model Using RNA Sequencing Data
192. Development of nomograms for prediction of disease recurrence according to the surgical approach in patients with stage IB cervical cancer
193. Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study.
194. Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis.
195. Robot-assisted inguinal sentinel lymph node biopsy in primary yolk sac tumor of the vulva
196. Robot-assisted anterior pelvic exenteration in vulvovaginal malignant melanoma
197. Predicting survival outcomes in ovarian cancer using gene expression data
198. Predicting survival outcomes in ovarian cancer using gene expression data
199. Precision cancer medicine in ovarian cancer.
200. SY05-5 Clinical trials for advanced or recurrent cervical cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.